Skip to main content

History and the Technological Evolution of Stereotactic Body Radiotherapy

  • Chapter
  • First Online:
  • 1450 Accesses

Abstract

After the discovery of use of therapeutic radiation, tremendous advances have been made towards targeted radiation. 3D conformal and intensity modulation have led to conformal therapy minimizing normal tissue toxicity. Improvements in diagnostic technology in delineating tumors, complex planning algorithms, robotic tracking devices, and megavoltage and particle beams have led to use of ablative radiation in the body with minimal side effects.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Lax I, Blomgren H, Näslund I, Svanström R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol. 1994;33(6):677–83.

    Article  CAS  PubMed  Google Scholar 

  2. Papiez L, Timmerman R, DesRosiers C, Randall M. Extracranial stereotactic radioablation: physical principles. Acta Oncol. 2003;42(8):882–94.

    Article  PubMed  Google Scholar 

  3. Papiez L, Moskvin V, Timmerman R. The physics and dosimetry of SBRT: treatment planning. In: Stereotactic body radiotherapy. Lippincott Williams & Wilkins: Philadelphia; 2004. p. 160.

    Google Scholar 

  4. Timmerman R, Papiez L, Suntharalingam M. Extracranial stereotactic radiation delivery: expansion of technology beyond the brain. Technol Cancer Res Treat. 2003;2(2):153–60.

    PubMed  Google Scholar 

  5. Timmerman R, Galvin J, Michalski J, Straube W, Ibbott G, Martin E, et al. Accreditation and quality assurance for Radiation Therapy Oncology Group: multicenter clinical trials using stereotactic body radiation therapy in lung cancer. Acta Oncol. 2006;45(7):779–86.

    Article  PubMed  Google Scholar 

  6. Hiraoka M, Nagata Y. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the Japanese experience. Int J Clin Oncol. 2004;9(5):352–5.

    Article  PubMed  Google Scholar 

  7. Wolbrast B, Chin L, Svenson G. Optimization of radiation therapy: integral response of a model biological system. Int J Radiat Oncol Biol Phys. 1983;8:1761–82.

    Article  Google Scholar 

  8. Yaes RJ, Kalend A. Local stem cell depletion model for radiation myelitis. Int J Radiat Oncol Biol Phys. 1988;14(6):1247–59.

    Article  CAS  PubMed  Google Scholar 

  9. Park C, Papiez L, Zhang S, Story M, Timmerman RD. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70(3):847–52.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dharanipathy Rangaraj PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Rangaraj, D., Papiez, L.S. (2015). History and the Technological Evolution of Stereotactic Body Radiotherapy. In: Gaya, A., Mahadevan, A. (eds) Stereotactic Body Radiotherapy. Springer, London. https://doi.org/10.1007/978-0-85729-597-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-597-2_2

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-596-5

  • Online ISBN: 978-0-85729-597-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics